Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02436993 |
|---|---|
| Brief Title: | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab |
| First Submitted : | April 20, 2015 |
| First Submitted that Met QC Criteria : | May 4, 2015 |
| First Posted : | May 7, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 13, 2019 |
| Last Update Posted : | February 15, 2019 |